Zhu Yuefeng, Li Lubin, Liu Zhenjie, Cai Xiujun
Department of Vascular Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
Department of Vascular Surgery, Yantai Yuhuangding Hospital Affiliated with Qingdao Univeristy, Yantai, Shangdong, China.
Ann Vasc Surg. 2019 Nov;61:384-393. doi: 10.1016/j.avsg.2019.02.028. Epub 2019 May 8.
We sought to evaluate the feasibility, safety, and effectiveness of single-stage endovascular treatment with AngioJet rheolytic thrombectomy followed by stenting for iliac vein compression syndrome (IVCS) with secondary acute iliofemoral deep vein thrombosis (DVT).
We conducted a multiple-center prospective nonrandomized study to enroll patients with left-sided acute iliac-common femoral DVT secondary to IVCS. We performed AngioJet rheolytic thrombectomy followed by stenting to evaluate the success rate, periprocedural complications, hospital stay, clinical outcomes, and stent-patency rate.
A prospective cohort study of 19 consecutive patients diagnosed with IVCS and secondary acute iliac-common femoral DVT from October 2014 to April 2017 was conducted. The technique success rate was 94.7%, and the mean procedure time was 77 minutes. The 1-year primary and secondary patency rate was 84.2% and 94.7%, respectively.
Single-staged endovascular treatment with AngioJet rheolytic thrombectomy and stenting is feasible, safe, and effective for IVCS with secondary acute iliofemoral DVT.
我们旨在评估使用AngioJet血栓消融术进行单阶段血管内治疗，随后对伴有继发性急性髂股深静脉血栓形成（DVT）的髂静脉受压综合征（IVCS）进行支架置入术的可行性、安全性和有效性。
我们开展了一项多中心前瞻性非随机研究，纳入继发于IVCS的左侧急性髂总股静脉DVT患者。我们先进行AngioJet血栓消融术，然后进行支架置入术，以评估成功率、围手术期并发症、住院时间、临床结局和支架通畅率。
对2014年10月至2017年4月期间连续诊断为IVCS和继发性急性髂总股静脉DVT的19例患者进行了前瞻性队列研究。技术成功率为94.7%，平均手术时间为77分钟。1年的原发性和继发性通畅率分别为84.2%和94.7%。
对于伴有继发性急性髂股DVT的IVCS，采用AngioJet血栓消融术和支架置入术进行单阶段血管内治疗是可行、安全且有效的。
